I'm going to try to attempt to develop some growth scenarios for Echo over the next 1 to 5 years. I think it would be really interesting to examine the potential for sales improvement and PPS increase as the company potentialy releases multiple FDA-approved medical device products.
Its going to take a bit of back of the napkin calculations and rough "guesstimates" on how many licensing agreements Echo will ink going forward and what the compensation structure is for each. But, I think I can get a pretty close idea of where things could go with Zero (this seems highly unlikely today), One, and Two products to market. Forecasting income for a 3rd potential product is tough because we don't even know which market it will target.
For the record, mgt. has stated that the total market opportunity for its first two products is >$15 billion, the lion's share be attributable to continuous blood glucose monitoring for Diabetics.
Any feedback or suggestions for variables in my analysis will be warmly welcomed and incorporated so long as they make sense.
